GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 2005-2009  (2)
Document type
Publisher
Years
Year
  • 1
    Publication Date: 2019-07-17
    Description: Preliminary results are presented from the first validation of geophysical dataproducts (ice concentration, snow thickness on sea ice ( ) and ice temperature ( ) fromthe NASA EOS Aqua AMSR-E sensor, in East Antarctica (in September-October 2003). Thechallenge of collecting sufficient measurements with which to adequately validate thecoarse-resolution AMSR-E data products was addressed by means of a hierarchicalapproach, using detailed in situ measurements, digital aerial photography and other satellitedata. Initial results indicate that, at least under cold conditions with a dry snowcover, thereis a reasonably close agreement between satellite- and aerial photo-derived iceconcentrations i.e., 97.2 ±3.6% for NT2 and 96.5 ±2.5% for BBA algorithms versus 94.3±10% for the aerial photos. In general, the AMSR-E concentration represents a slightoverestimate of the actual concentration, with the largest discrepancies occurring in regionscontaining a relatively high proportion of thin ice. Although the AMSR-E concentrations fromthe NT2 and BBA algorithms are similar on average, differences of 〉5% occur on a point-by-point basis, again related to thin ice distribution. The AMSR-E ice temperature ( ) productagrees with coincident surface measurements to within approximately 0.5o C. Regardingsnow thickness, the AMSR retrieval is a significant underestimate compared to in situmeasurements weighted by the percentage of thin ice (and open water) present. For thecase study analysed, the underestimate was 46% for the overall average, but 23%compared to smooth ice measurements. An encouraging factor is that the spatialdistribution of the AMSR-E product follows an expected and consistent spatial pattern,suggesting that the observed difference may be an offset (at least under freezingconditions). Areas of discrepancy are identified, and the need for future work highlighted.
    Repository Name: EPIC Alfred Wegener Institut
    Type: Article , isiRev
    Format: application/pdf
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Background Olopatadine hydrochloride (olopatadine; Allelock®) is one of the second-generation antihistamines that are treated for allergic disorders such as rhinitis, urticaria and eczema dermatitis. Olopatadine has recently been shown to have inhibitory effects on the chronic contact hypersensitivity induced by repeated application of oxazolone in mice. Although topical steroids have widely been prescribed for atopic dermatitis, a relapse often occurs within several days after discontinuation of their prolonged use.Objectives We investigated the possible efficacy of olopatadine against the relapse after discontinuation of prolonged use of topical prednisolone in the Balb/c mice with oxazolone-induced chronic contact hypersensitivity.Methods Mice with the chronic contact hypersensitivity induced by repeated application of oxazolone were treated with olopatadine as a sequential therapeutic agent. The effects of olopatadine were quantified by measurements of ear-swelling, and levels of cytokines and histamine in the lesioned ear.Results Topical prednisolone (0.05 mg/ear/day) significantly inhibited the increases in ear swelling and production of IL-1β, IL-4, IL-18, granulocyte-macrophage colony-stimulating factor (GM-CSF) and histamine. However, after discontinuation of the treatment with topical prednisolone, the inflammation relapsed and the IL-4 level exceeded the control one. The sequential treatment with olopatadine (10 mg/kg/day) after discontinuation of the treatment with topical prednisolone alone, or topical prednisolone with olopatadine, significantly inhibited the increases in ear swelling and levels of IL-1β, IL-4, IL-18, GM-CSF, nerve growth factor and histamine.Conclusions These results indicate that olopatadine is an antihistamine agent having inhibitory activities against the rebound phenomenon following the discontinuation of topical steroid therapy. Olopatadine is thus expected to be a sequential therapeutic agent after discontinuation of the chronic treatment with a topical steroid.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...